The price of Serplulimab Injection varies with specifications, regions, medical institutions and medical insurance policies, usually ranging from US$$290 to U$$724 per vial.
For the exact cost, please consult formal medical institutions or pharmacies. Purchasing from informal channels is not recommended.
This is a prescription drug and must be used strictly under medical advice; do not adjust the dosage or stop the medication on your own.
1. Price Range & Influencing Factors
Specification differences
Prices vary by dosage (e.g., 100 mg, 300 mg), with higher dosages generally having higher unit prices.
Regional policies
The final out-of-pocket cost is affected by local medical insurance reimbursement rates and medical institution pricing standards.
Purchase channels
Prices may differ between public hospitals, private hospitals and designated pharmacies; formal channels are strongly recommended.
2. Price Inquiry Suggestions
Consult medical institutions
Contact the pharmacy of your treating hospital or your attending physician for an accurate quote.
Verify via official channels
Check the manufacturer’s official website or customer service hotline for reference pricing.
Confirm medical insurance coverage
Serplulimab is covered by medical insurance in some cities; consult your local medical insurance authority for reimbursement terms.
3. Medication Precautions
Strictly follow medical advice
A personalized regimen will be prescribed by a doctor based on the patient’s condition, weight and other factors; self-administration is prohibited.
Storage requirements
Store in a dark, refrigerated environment (2–8°C), avoid freezing or shaking, and use within the specified time after opening.
Adverse reaction monitoring
Immune-related adverse reactions (e.g., pneumonitis, hepatitis) may occur. Undergo regular follow-ups and inform your doctor of any discomfort immediately.
4. Medical Guidance
Indications
Serplulimab is mainly indicated for the treatment of specific advanced solid tumors (e.g., small cell lung cancer). Applicability must be confirmed by pathological testing.
Multidisciplinary consultation
For complex cases, multidisciplinary evaluation at a specialized cancer hospital is recommended to develop a comprehensive treatment plan.
Treatment cycle management
Use the drug as scheduled per the treatment course; undergo regular imaging and blood tests during treatment.
If you need to use this drug, please complete the risk assessment and treatment plan under the guidance of an oncologist or hematologist, and keep complete medical records.
Seek emergency medical care immediately if symptoms such as fever or dyspnea occur during treatment.
